Salma B. Rafi

775 citations
7 papers · 486 indexed · h-index 7
Topics
Antimicrobial Peptides and Activities (2 papers)RNA modifications and cancer (1 paper)Chemical Synthesis and Analysis (1 paper)

In The Last Decade

Salma B. Rafi

7 papers receiving 476 citations

Peers

Salma B. Rafi
Comparison fields: 5 of 81
  • Molecular Biology 303
  • Oncology 88
  • Computational Theory and Mathematics 87
  • Cancer Research 76
  • Organic Chemistry 72
Replace Amy E. Mercer with:
Amy E. Mercer United Kingdom
Anna Jansson Sweden
Indu R. Chandrashekaran Australia
Christine Latour France
Gonzalo E. González‐Páez United States
Gabriela Mustata United States
Jason van Rooyen South Africa
Naoyuki Asakawa Japan
Martina Sigal United States
Katarzyna Groborz Poland
Salma B. Rafi relative to Amy E. Mercer United Kingdom Amy E. Mercer's profile →
Citations per field
00.5×6.8×
Amy E. Mercer · 1×
Citations per year

Countries citing papers authored by Salma B. Rafi

Since Specialization
Citations

This map shows the geographic impact of Salma B. Rafi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Salma B. Rafi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Salma B. Rafi more than expected).

Fields of papers citing papers by Salma B. Rafi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Salma B. Rafi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Salma B. Rafi. The network helps show where Salma B. Rafi may publish in the future.

Co-authorship network of co-authors of Salma B. Rafi

This figure shows the co-authorship network connecting the top 25 collaborators of Salma B. Rafi. A scholar is included among the top collaborators of Salma B. Rafi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Salma B. Rafi. Salma B. Rafi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
#WorkIndexed citations
1 104
2 122
3 89
4 34
5 93
6 30
7
Drug resistance in Mycobacterium tuberculosis: a four years experience.
14

About Salma B. Rafi

Salma B. Rafi is a scholar working on Microbiology, Molecular Medicine and Parasitology, having authored 7 papers that have together received 486 indexed citations. Recurring topics across this work include Antimicrobial Peptides and Activities (2 papers), RNA modifications and cancer (1 paper) and Chemical Synthesis and Analysis (1 paper). The work is most often cited by research in Computational Theory and Mathematics (87 citations), Cancer Research (76 citations) and Parasitology (29 citations). Salma B. Rafi has collaborated with scholars based in United States, China and Pakistan. Frequent co-authors include Matthew P. Jacobson, P. Vedantham, Brian R. Hearn, Adam R. Renslo, Byron DeLaBarre, Liang Tong, Wei Jia, H. James Harwood, Silvana Leit and Jun Kuai. Their work appears in journals such as Nature, Journal of Medicinal Chemistry and Science Advances.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026